Projecting future drug expenditures--2011 (original) (raw)

Projecting future drug expenditures--2009

Robert Hunkler

American Journal of Health-System Pharmacy, 2009

View PDFchevron_right

Projecting future drug expenditures--2007

Robert Hunkler

American Journal of Health-System Pharmacy, 2007

View PDFchevron_right

Projecting future drug expenditures--2010

Robert Hunkler

American Journal of Health-System Pharmacy, 2010

View PDFchevron_right

Projecting future drug expenditures--2012

Edward Li

American Journal of Health-System Pharmacy, 2012

View PDFchevron_right

Projecting future drug expenditures--2006

Robert Hunkler

American Journal of Health-System Pharmacy, 2006

View PDFchevron_right

Trends in annual drug expenditure – a 16 year perspective of a public healthcare maintenance organization

Daniel Kurnik

Israel Journal of Health Policy Research, 2016

View PDFchevron_right

Explaining drug spending trends: does perception match reality?

Anita Chawla

Health Affairs, 2000

View PDFchevron_right

Stemming the Escalating Cost of Prescription Drugs: A Position Paper of the American College of Physicians

Hilary Daniel

Annals of internal medicine, 2016

View PDFchevron_right

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey

Frank Lichtenberg

2001

View PDFchevron_right

Pharmaceuticals: cost containment, pricing, reimbursement

Rama Lakshminarayanan

2005

View PDFchevron_right

Recent Trends in Prescription Drug Use and Expenditures by Medicaid Enrollees

Eric Sarpong

2012

View PDFchevron_right

Decomposing changes in the growth of U.S. prescription drug use and expenditures, 1999‐2016

Thomas Selden

Health Services Research, 2019

View PDFchevron_right

The effect of newer drugs on health spending: do they really increase the costs?

Abdulkadir Civan

Health Economics, 2009

View PDFchevron_right

Retail Prescription Drug Spending In The National Health Accounts

C. Smith

Health Affairs, 2004

View PDFchevron_right

Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV

Jayashri Sankaranarayanan

Value in Health

View PDFchevron_right

Pharmacoeconomic Evaluation to Assist Prescription Drug Pricing

RJ Bonk

PharmacoEconomics, 1993

View PDFchevron_right

Medicare: Prescription Drug Expenditures, 1997

Paulette Morgan

View PDFchevron_right

Cost containment strategies for prescription drugs: assessing the evidence in the literature

John Hoadley

2005

View PDFchevron_right

Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians

Hilary Daniel

Annals of Internal Medicine, 2019

View PDFchevron_right

Effects Of New Drugs On Overall Health Spending: Frank Lichtenberg Responds

Frank Lichtenberg

Health Affairs, 2007

View PDFchevron_right

2005_Exploration of the Impact of Preferred Drug Lists on Hospital and Physician Visits and the Costs to Medicaid.pdf

Matthew Murawski

View PDFchevron_right

Impact of managed care on prescription drug use

Alan Lyles

Health Affairs, 1991

View PDFchevron_right

How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives

Ozden Ali, Basak Topaler

View PDFchevron_right

Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options

Ulf Bergman

Clinical pharmacology and therapeutics, 1990

View PDFchevron_right

Benefits and costs of newer drugs: an update

Frank Lichtenberg

Managerial and Decision Economics, 2007

View PDFchevron_right

Consequences of the 340B Drug Pricing Program

Jay Bhatt

The New England journal of medicine, 2018

View PDFchevron_right

Shifting North American drug markets and challenges for the system of care

Dr. George Budd

International Journal of Mental Health Systems

View PDFchevron_right

Pharmacoeconomics: Identifying the Issues Overview and Advisory Panel Report Summary

Donna Rindress, Jean Gagnon, Alan Bakst, Joseph Jackson

Value in Health, 1999

View PDFchevron_right

Financial Incentives And Drug Spending In Managed Care Incentives for both physicians and patients can interact to help curb spending in this increasingly costly sector

Martin Gaynor

View PDFchevron_right

Pharmacy utilization and the Medicare modernization act

Adam Roumm, Vittorio Maio

Milbank …, 2005

View PDFchevron_right

Impact of drug shortages on U.S. health systems

Burgunda Sweet

American Journal of Health-System Pharmacy, 2011

View PDFchevron_right

The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality

Frank Lichtenberg

1996

View PDFchevron_right

Forecasting drug utilization and expenditure in a metropolitan health region

Seher Korkmaz

BMC Health Services Research, 2010

View PDFchevron_right